Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10076
Novartis
NVS
$287B
| $168K | ﹤0.01% |
1,661
+1,487
| +855% | +$149K |
|
10077
PUT
Allogene Therapeutics
ALLO
$708M
| $167K | ﹤0.01% |
33,700
+8,100
| +32% | +$43.8K |
|
10078
Montauk Renewables
MNTK
$268M
| $167K | ﹤0.01% |
22,491
+13,466
| +149% | +$92.8K |
|
10079
PUT
Oxford Industries
OXM
$543M
| $167K | ﹤0.01% |
1,700
-10,400
| -86% | -$1.07M |
|
10080
PUT
TriplePoint Venture Growth BDC
TPVG
$221M
| $167K | ﹤0.01% |
14,200
-3,800
| -21% | -$42.9K |
|
10081
CALL
Victory Capital Holdings
VCTR
$7.27B
| $167K | ﹤0.01% |
5,300
+2,000
| +61% | +$61.8K |
|
|
CWBC
10082
Community West Bancshares
CWBC
$708M
| $167K | ﹤0.01% |
10,817
-2,657
| -20% | -$41.2K |
|
10083
PUT
Wintrust Financial
WTFC
$11B
| $167K | ﹤0.01% |
2,300
-4,700
| -67% | -$320K |
|
10084
PUT
Weis Markets
WMK
$1.76B
| $167K | ﹤0.01% |
2,600
+600
| +30% | +$43.6K |
|
|
DDL
10085
Dingdong
DDL
$523M
| $167K | ﹤0.01% |
+54,026
| New | +$180K |
|
|
BRT
10086
BRT Apartments
BRT
$270M
| $167K | ﹤0.01% |
8,431
+6,045
| +253% | +$112K |
|
10087
PUT
Vera Therapeutics
VERA
$2.28B
| $167K | ﹤0.01% |
10,400
+8,600
| +478% | +$77.7K |
|
10088
CALL
Consumer Portfolio Services
CPSS
$205M
| $167K | ﹤0.01% |
14,300
-100
| -0.7% | -$1.08K |
|
10089
PUT
First Interstate BancSystem
FIBK
$3.73B
| $167K | ﹤0.01% |
7,000
+600
| +9% | +$15.1K |
|
|
EDN
10090
Edenor
EDN
$1.01B
| $167K | ﹤0.01% |
10,822
-9,829
| -48% | -$101K |
|
10091
PUT
Revvity
RVTY
$13B
| $166K | ﹤0.01% |
1,400
-1,200
| -46% | -$147K |
|
|
LTC
10092
LTC Properties
LTC
$2.17B
| $166K | ﹤0.01% |
5,036
-61,261
| -92% | -$2.05M |
|
|
BWIN
10093
PUT
Baldwin Insurance Group
BWIN
$3.05B
| $166K | ﹤0.01% |
6,700
+3,700
| +123% | +$87.6K |
|
|
PRA
10094
CALL
DELISTED
ProAssurance
PRA
| $166K | ﹤0.01% |
11,000
+4,600
| +72% | +$72.4K |
|
10095
PUT
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
| $166K | ﹤0.01% |
2,100
-3,000
| -59% | -$238K |
|
10096
Prelude Therapeutics
PRLD
$443M
| $166K | ﹤0.01% |
+36,869
| New | +$220K |
|
10097
CALL
KRONOS Worldwide
KRO
$975M
| $166K | ﹤0.01% |
19,000
+8,700
| +84% | +$76.7K |
|
10098
Nuveen Municipal Credit Income Fund
NZF
$2.44B
| $166K | ﹤0.01% |
+14,225
| New | +$165K |
|
10099
PUT
Amcor
AMCR
$21.3B
| $166K | ﹤0.01% |
3,320
+2,640
| +388% | +$138K |
|
10100
PUT
LegalZoom.com
LZ
$963M
| $165K | ﹤0.01% |
13,700
-61,100
| -82% | -$646K |
|
Similar funds
Citadel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.
- Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
- Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Citadel Advisors opened 1,205 new positions and closed 1,562 in Q2 2023.
- Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.